Search Results - "hematologic malignancies"

Histone Deacetylase 6 as a Therapeutic Target in B cell-associated Hematological Malignancies by Jia Yang, Dengwen Li, Jun Zhou, Jun Zhou

Connect to this object online.

Carbapenem-Resistant Enterobacteriaceae-Implications for Treating Acute Leukemias, a Subgroup of Hematological Malignancies by Kristin Ølfarnes Storhaug, Dag Harald Skutlaberg, Bent Are Hansen, Håkon Reikvam, Øystein Wendelbo

Connect to this object online.

Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies by Deepak Narayanan Iyer, Omar Faruq, Lun Zhang, Nasrin Rastgoo, Aijun Liu, Hong Chang

Connect to this object online.

Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens? by Gedik H, Şimşek F, Kantürk A, Yildirmak T, Arica D, Aydin D, Demirel N, Yokuş O

Connect to this object online.

Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience by Lianna J. Marks, Jennifer A. Oberg, Danielle Pendrick, Anthony N. Sireci, Chana Glasser, Carrie Coval, Rebecca J. Zylber, Wendy K. Chung, Wendy K. Chung, Jiuhong Pang, Andrew T. Turk, Susan J. Hsiao, Mahesh M. Mansukhani, Mahesh M. Mansukhani, Julia L. Glade Bender, Julia L. Glade Bender, Andrew L. Kung, Maria Luisa Sulis, Maria Luisa Sulis

Connect to this object online.

Development and implementation of "handshake rounds": An antibiotic stewardship intervention for hospitalized adult patients with hematologic malignancies by Chelsea A. Gorsline, Ryan M. Miller, Laura J. Bobbitt, Gowri Satyanarayana, Muhamed Baljevic, Milner B. O. Staub

Connect to this object online.

Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate by Marina Zoéga Hayashida, Camila Arai Seque, Milvia Maria Simões e Silva Enokihara, Adriana Maria Porro

Connect to this object online.

Fostering Palliative Care Through Digital Intervention: A Platform for Adult Patients With Hematologic Malignancies by Lefteris Koumakis, Fatima Schera, Heather Parker, Panos Bonotis, Maria Chatzimina, Panagiotis Argyropaidas, Giorgos Zacharioudakis, Michael Schäfer, Christine Kakalou, Christina Karamanidou, Jana Didi, Eleni Kazantzaki, Lydia Scarfo, Kostas Marias, Pantelis Natsiavas

Connect to this object online.

Cutaneous invasive fungal infections in pediatric hematological malignancies: A case series and review of literature by Aniketh Umesh, Chandana S. Pai, Vinay Munikoty Venkatesh, Archana Melavarige Venkatagiri, Vasudeva Bhat K, Vishwapriya M. Godkhindi, Kanthilatha Pai

Connect to this object online.

Targeting high-risk groups in the post-pandemic era: A focus on pediatric hematological malignancies by Nan-Chang Chiu, Hsin Chi, Chien-Yu Lin

Connect to this object online.

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek

Connect to this object online.

Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies by Ilaria Laurenzana, Daniela Lamorte, Stefania Trino, Luciana De Luca, Concetta Ambrosino, Pietro Zoppoli, Vitalba Ruggieri, Luigi Del Vecchio, Pellegrino Musto, Antonella Caivano, Geppino Falco

Connect to this object online.

Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek

Connect to this object online.

A case of eosinophilic dermatosis of hematologic malignancy with tissue-based Th2 cytokine profiling by Suzanne Xu, BS, Katelyn Singh, BA, Jennifer McNiff, MD, William Damsky, MD, PhD, Jeffrey R. Gehlhausen, MD, PhD

Connect to this object online.

Eosinophilic fasciitis may present as a paraneoplastic syndrome of hematological malignancies-A systematic review by Sikander Chohan, BS, Nikita Wong, MS, Jamie Hanson, MD, Muhammad Osto, MD, Steven Daveluy, MD

Connect to this object online.

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation by Bao W, Liu R, Xia G, Wang F, Chen B

Connect to this object online.

Is HALP score a predictor of poor prognosis in patients with hematologic malignancies admitted to the intensive care unit? by Sevil Sadri, Burcu Tunay

Connect to this object online.

Population pharmacokinetic and exposure‐response analyses of ivosidenib in patients with IDH1‐mutant advanced hematologic malignancies by Xuemin Jiang, Russ Wada, Bill Poland, Huub Jan Kleijn, Bin Fan, Guowen Liu, Hua Liu, Stephanie Kapsalis, Hua Yang, Kha Le

Connect to this object online.

The efficacy of supragingival irrigation with chlorhexidine for plaque control in patients with hematologic malignancies: A randomized clinical trial by Pegah Mosannen Mozafari, Seyed MohammadReza Aboutorabzadeh, Mahdokht Rashed Mohassel, Mohammad Mahdi Koshyar, Maryam Amirchaghmaghi, Ershad Aghasizadeh, Parisa Karoos, Amir Abbas Azarian

Connect to this object online.

Development and validation of an LC-MS/MS method for ruxolitinib quantification: advancing personalized therapy in hematologic malignancies by Na Li, Na Li, Huiying Zhang, Huiying Zhang, Haochen Bai, Kaizhi Lu, Kaizhi Lu

Connect to this object online.